This discussion will highlight the following 9 specific points that related to metabolic acidosis caused by various toxins. The current recommendation suggests that alcohol dehydrogenase inhibitor fomepizole is preferred to ethanol in treatment of methanol and ethylene glycol poisoning, but analysis of the enzyme kinetics indicates that ethanol is a better alternative. In the presence of a modest increase in serum osmolal gap (<30 mOsm/L), the starting dose of ethanol should be far less than the usual recommended dose. One can take advantage of the high vapor pressure of methanol in the treatment of methanol poisoning when hemodialysis is not readily available. Profuse sweating with increased water ingestion can be highly effective in reducing methanol levels. Impaired production of ammonia by the proximal tubule of the kidney plays a major role in the development of metabolic acidosis in pyroglutamic acidosis. Glycine, not oxalate, is the main final end product of ethylene glycol metabolism. Metabolism of ethylene glycol to oxalate, albeit important clinically, represents less than 1% of ethylene glycol disposal. Urine osmolal gap would be useful in the diagnosis of ethylene glycol poisoning, but not in methanol poisoning. Hemodialysis is important in the treatment of methanol poisoning and ethylene glycol poisoning with renal impairment, with or without fomepizole or ethanol treatment. Severe leucocytosis is a highly sensitive indicator of ethylene glycol poisoning. Uncoupling of oxidative phosphorylation by salicylate can explain most of the manifestations of salicylate poisoning.
The following contains short discussions on certain aspects of toxin-induced metabolic acidosis, which represent this author's unconventional views on them or highlight some underemphasized or misunderstood aspects of these disorders.
Which is better: ethanol or fomepizole?
The current consensus is that fomepizole is better than ethanol for treatment of methanol and ethylene glycol poisoning, mainly on the basis that it has fewer side effects and is easier to use 1, 2) , although that the cost of fomepizole, at $1,000 for a 1.5 g ampule or an average cost of about $4,000 per patient, is much greater than that of ethanol. The comparison of side effects is based on the usual recommended dose of ethanol, which is set to maintain plasma levels at 100 mg/dL or higher until plasma methanol or ethylene glycol levels decrease below 20 mg/ would indeed be severely intoxicated, and develop side effects.
The recommended maintenance level of plasma ethanol for treatment of methanol and ethylene glycol poisoning has not been determined either by careful theoretical analysis or by empirical evidence 3) . Ethanol is used to treat intoxication of methanol and ethylene glycol because hepatic ethanol dehydrogenase is the main enzyme for their metabolism, but the enzyme has much greater affinity to ethanol than to either chemical. Since toxic effects of these alcohols result from production of their metabolites, administration of ethanol, being the preferred substrate of the enzyme, prevents metabolism of toxic alcohols. In fact, Km values of ethylene glycol and methanol are about 40-50 fold greater than that of ethanol 4, 5) . Km for ethanol is 5.2 mg/dL, while those for methanol and ethylene glycol are 171.7 and 275.2 mg/dL respectively 4, 5) .
Patients with ethylene glycol and methanol poisoning have varying plasma levels of the toxic alcohols at the time of admission to the hospital. For example, in case reports by Ekins et al., the initial plasma levels ranged between 46 mg/dL and 377 mg/dL 6) . Similarly, patients of Pappas and Silverman had plasma methanol levels between 42 and 464 mg/dL 7) . Yet, everyone was treated with ethanol at the same plasma level, 100 mg/dL. Furthermore, during hemodialysis, plasma levels of toxic alcohols decrease rapidly, but it is recommended to maintain the same plasma levels of ethanol. Davis et al. treated a patient with a plasma ethylene glycol level of 888 mg/dL (143 mmol/L) 8) , with the same ethanol dose. Schwerk et al. treated a patient with a even higher level of ethylene glycol, 3,900 mg/dL (629 mmol/L), with the standard dose of ethanol 9) . The highest concentration of plasma methanol intoxication was the case reported by Martens et al. 10) , and the patient had a plasma methanol of 921.2 mg/dL, and was again treated with the standard dose of ethanol. However, as the drug is removed, the toxic alcohols are also removed, and hence competition is lessened also.
Thus, increases in fomepizole dosage would be necessary during hemodialysis.
There is evidence that H-2 blockers inhibit alcohol dehydrogenase and would inhibit the metabolism of methanol 16) . Indeed, ranitidine has been used to treat methanol toxicity in rats 17) . Perhaps, this class of drugs could turn out to be a much cheaper alternative to fomepizole in treating methanol poisoning. On the other hand, inhibition of ethylene glycol by H-2 blockers is not as effective. 
Sauna bath and exercise for methanol intoxication

Leucocytosis in ethylene glycol poisoning: possible diagnostic value
Leucocytosis is a consistent finding in ethylene glycol poisoning, and usually it is quite severe [19] [20] [21] [22] . Mydlik et al. noted, in his review of the record of 17 patients with ethylene glycol poisoning, leucocytosis in all of them 23) . It is possible that the leucocytosis is in response to the stress of severe metabolic acidosis, but leucocytosis is not always found or as severe in metabolic acidosis caused by other toxins. The mechanism is unknown, but is tempting to speculate that it could be a response to tissue deposits of calcium oxalate crystals. Leucocytosis is a common clinical manifestation, and is not a specific finding for ethylene glycol poisoning, but its universal finding makes it a useful diagnostic tool in that one can rule ethylene glycol poisoning in the absence of leucocytosis.
Oxalate is not the major endproduct of ethylene glycol metabolism
In the discussion of ethylene glycol metabolism, most authorities emphasize metabolism of ethylene glycol to oxalic acid as the major metabolic pathway 14) . It is clear that production of oxalic acid is a clinically relevant and diagnostically useful pathway of ethylene glycol metabolism. Appearance of calcium oxalate crystals in urine is almost universal, and deposits of calcium oxalate in the tissues including the kidney is well recognized, and is implicated as the cause of some of the toxic effects of ethylene glycol 24, 25) . Oxalate over-production also explains hypocalcemia, which is very common in ethylene glycol poisoning. However, quantitatively, oxalate is a minor byproduct of ethylene glycol poisoning. The immediate precursor of oxalate is glyoxylate, which is converted to oxalate by the action of lactate dehydrogenase (LDH). The most important pathway is conversion to glycine by the action of alanine-glyoxylate aminotransferase with vitamin B6 as a co-factor 26) . 
Ethanol and fomepizole are not useful in toluene and benzyl alcohol poisoning
Ethanol dehydrogenase is a non-specific enzyme with many substrates including benzyl alcohol. However, either ethanol or fomepizole has been tried or advisable to treat benzyl alcohol poisoning. One of the reasons for not using ethanol to treat benzyl alcohol poisoning is that the main enzyme responsible for metabolism of benzyl alcohol in humans is nicotinamide adenine dinucleotide phosphate (NADPH)-dependent cytochrome-450 oxidase 27) , not alcohol dehydrogenase. In certain species, alcohol dehydrogenase metabolizes benzyl alcohol, but the affinity of benzyl alcohol to alcohol dehydrogenase is actually greater than ethanol. Furthermore, metabolic endproducts of benzyl alcohol, benzoic acid and hippuric acid, do not have much harmful effects, but actually may possess some beneficial effects. Both acids are the main organic acids present in cranberry juice, and are thought to be responsible for its antibacterial effects in the prevention of urinary tract infection (UTI).
Uncoupling of oxidative phosphorylation is the main mechanism of salicylate poisoning
Salicylate poisoning, a major cause of poisoning because of its widespread use, has many different clinical manifestations, and one unifying mechanism that could explain most of the manifestations of salicylate poisoning is uncoupling of oxidative phosphorylation. Salicylate is an uncoupler 28, 29) , and has a chemical structure that is quite similar to a better known uncoupler, 2, 4-dinitrophenol. . There is some evidence that salicylate inhibits Krebs cycle 32) , but this would cause lactic acidosis, not excessive consumption of glucose. The following are some of the manifestations of salicylate poisoning that can be explained by uncoupling.
Fever
Aspirin is an antipyretic, but fever is common in salicylate poisoning, and this is explained by excessive glucose utilization creating heat.
Tinnitus and deafness
ATP deficiency of inner ear due to uncoupling could be the cause.
Ketoacidosis
This is more common in children and women, and is likely to be due to increased production of lipolytic hormones in response to central hypoglycemia. Hypoglycemia is common in salicylate poisoning 33) , and sometimes brain glucose is low while plasma glucose is normal because of increased utilization of glucose due to uncoupling that is most pronounced in the brain 34) .
Lactic acidosis
Extensive uncoupling causes deficiency of ATP, which increases production of nicotinamide adenine dinucleotide (NADH) and lactic acidosis.
Respiratory alkalosis
Respiratory alkalosis is the commonest acid-base disorder of salicylate poisoning, and the current explanation is that the drug stimulates the respiratory center directly.
However, one plausible explanation is that increased glucose utilization in the brain would increase production of CO 2 in the brain including the central respiratory center.
Thus, what appears to be systemic respiratory alkalosis could be a normal physiological response to the central nervous system (CNS) respiratory acidosis.
Urine osmolal gap for diagnosis of ethylene glycol poisoning
Unlike methanol, ethylene glycol is substantially concentrated in the urine. Mean renal clearance has been measured at 27.5 mL/min with fractional excretion of 19.8% 35) . Similar clearance values were obtained by Harry et al. 36) . This would mean that for a person who has 2 L of urine output, the urinary concentration of ethylene glycol would be about 10 times the concentration in the blood. Perhaps, experiments can be carried out in an animal model.
